4,5-Disubstituted 2-deoxystreptamines are a class of semi-synthetic derivatives derived from the natural product streptamine. These compounds feature modifications at the 4 and 5 positions on the amino group, typically introducing substituents such as methyl, ethyl, or other functional groups to alter their biological properties. The 2-deoxy component distinguishes these molecules from their parent streptamines by replacing the hydroxyl group at C-2 with a hydrogen atom, potentially affecting their pharmacokinetic and pharmacodynamic profiles. These derivatives have garnered significant interest due to their diverse bioactivities, including potential applications in antibiotic development, anti-inflammatory effects, and other therapeutic areas. Their structural modifications may enhance drug efficacy, improve solubility, or reduce side effects compared to the natural product. However, detailed studies are required to fully elucidate their mechanisms of action and optimal use in various medical contexts. Research into these compounds often involves rigorous chemical synthesis, purification, and biological evaluation to identify promising leads for further development as pharmaceutical agents.